Management of Antithrombotic Therapy in Left Ventricular Thrombus: A Position Paper of the Italian Society of Hemostasis and Thrombosis (SISET)
Thrombosis and Haemostasis · 01.08.2026 · 126 (08) · 765-774
DOI: 10.1055/a-2702-2298 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.08.2026. Verfasst von Emanuele Valeriani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Surgical Specialty and Anesthesiology, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Thrombosis, Fibrinolytic Agents, Anticoagulants, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Left ventricular thrombus (LVT) represents a potential life-threatening condition burdened by a significant risk of systemic embolism. Despite the relevance of the disease, there are scanty data on antithrombotic management of LVT mostly deriving from small observational studies and few randomized controlled trials. It has been reported that anticoagulant therapy reduces the rate of thrombus formation, allows thrombus resolution in most cases, and limits the risk of embolic complications. Several issues, however, still remain unresolved and clinicians caring for these patients have to decide on the need and on the regimen of antithrombotic therapy based on their expertise and data from different clinical scenario. This position paper of the Italian Society of Hemostasis and Thrombosis (SISET) aims to provide practical advice and guidance in the form of text, tables, and figures for clinicians dealing with LVT. Relevant clinical questions related to LVT have been identified concerning the identification of patients at risk; the role of anticoagulant prophylaxis on LVT development; the type, dose, and duration of anticoagulant therapy; and the management of patients receiving concomitant antiplatelet therapy. A systematic search has been performed to identify available evidence on the topic that has been carefully and critically reviewed by the national expert authors to support the suggestions and recommendations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Surgical Specialty and Anesthesiology, Sapienza University of Rome, Rome, Italy.
- Department of Infectious Disease, Azienda Ospedaliero-Universitaria Policlinico Umberto I, Roma, Italy.
- Dipartimento di Medicina Sperimentale e Clinica, Università di Firenze, Florence, Italy.
- Department of Medicine and Surgery, University of Insubria, Varese, Italy.
- Department of Medical and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
- IRCCS Neuromed, Pozzilli, Italy.
ORCID-Profile: Emanuele Valeriani
Zitieren
APA
Valeriani, E., Pannunzio, A., Menichelli, D., Prisco, D., Ageno, W., Pastori, D., & Pignatelli, P. (2026). Management of Antithrombotic Therapy in Left Ventricular Thrombus: A Position Paper of the Italian Society of Hemostasis and Thrombosis (SISET). Thrombosis and Haemostasis, 126(08), 765-774. https://doi.org/10.1055/a-2702-2298
Vancouver
Valeriani E, Pannunzio A, Menichelli D, Prisco D, Ageno W, Pastori D, et al. Management of Antithrombotic Therapy in Left Ventricular Thrombus: A Position Paper of the Italian Society of Hemostasis and Thrombosis (SISET). Thrombosis and Haemostasis. 2026;126(08):765-774. doi:10.1055/a-2702-2298
BibTeX
@article{Valeriani2026,
author = {Valeriani, Emanuele and Pannunzio, Arianna and Menichelli, Danilo and Prisco, Domenico and Ageno, Walter and Pastori, Daniele and Pignatelli, Pasquale},
title = {Management of Antithrombotic Therapy in Left Ventricular Thrombus: A Position Paper of the Italian Society of Hemostasis and Thrombosis (SISET)},
journal = {Thrombosis and Haemostasis},
year = {2026},
volume = {126},
number = {08},
pages = {765--774},
doi = {10.1055/a-2702-2298}
}
EUVIMED